Introduction: Staphylococcus aureus is one of the main causes of hospital infections. The present study aimed to determine the antimicrobial effect of zinc oxide nanoparticles (ZnONPs) on the growth of mupirocin-resistant S. aureus isolates taken from hospital carriers. Methods: The samples were taken from the anterior nasal parts of 150 hospital staff in Gorgan, using a sterile swab. Being cultured on Mannitol salt agar, the suspected colonies were identified through gram staining as well as catalase, coagulase and DNase tests. Resistance of the strains to mupirocin was examined using microdilution broth test. The antibacterial effect of ZnONPs on the mupirocin-resistant strains was also investigated using agar well diffusion method. Results: In this study, 48 isolates (32%) were identified as S. aureus, out of which 3 isolates (6.2%) showed high resistance to mupirocin and 14 isolates (29.2%) showed low resistance to this antibiotic. The results of this study revealed that ZnONPs had the highest inhibitory effect on the growth of mupirocin-resistant S. aureus in the density of 400 mg/mL. Conclusion: The ZnONPs used in this study had a high dose-dependent antimicrobial activity against all drug-resistant S. aureus strains.
Introduction
Staphylococcus aureus is a major cause of skin and soft tissue infections, endocarditis, osteomyelitis, toxic shock syndrome (TSS), and the infections related to medical tools which could threaten human lives. 1, 2 Human being is the main carrier of S. aureus. This asymptomatic bacterium is able to settle on the skin or inside the nasal cavity of humans and animals, to the extent that about 20% of humans are permanent carriers of this bacterium. 3 In some hospitals, this bacterium is more commonly found in the intensive care unit (ICU) which could be lethal. Due to increasing drug resistance, this bacterium has now turned into an important hygiene problem worldwide. 4, 5 After observing the first case of methicillin--resistant Staphylococcus aureus (MRSA) (1960s), mupirocin was the first topical drug used to treat MRSA skin infections in 1986. This drug is a unique antimicrobial agent in comparison with other antibiotics, which is originated from Pseudomonas fluorescens. 6 Mupirocin (pseudomonic acid A) has the capacity to interact with isoleucyltRNA synthetase (IRS) and block protein synthesis. 7 Due to its short half-life after being injected and high protein connections, this drug is currently used in the topical form. Unfortunately, the current indiscriminate use of drugs has developed a relative drug resistance in this bacterium and has created resistant species of this bacterium which hinder treatment of some diseases. Therefore, it is recommended to use various combinations or antimicrobial agents such as nanoparticles to stop or control such resistance. 8, 9 Nanotechnology, a hotspot in science of materials, is used increasingly in researches and has applications related to human 10, 11 These combinations have been used as antimicrobial agents. ZnONPs act by destroying the bacterial walls and are effective in preventing antimicrobial activities in prosthesis and catheter surfaces due to the antimicrobial activities of zinc oxide as a coating material. 12, 13 This study aimed to evaluate and compare the antimicrobial effects of ZnONPs on the isolates of mupirocin-resistant S. aureus separated from the carrier staff of hospitals.
Methods

Bacterial Strains
In this study, 150 samples were isolated from 4 hospitals in Gorgan, North of Iran, during 2016-2017. Samples were taken by cotton swabs from the nose of a number of the personnel willing to participate in the study. Receiving no antibiotics over the past month and no systemic diseases or immune deficiencies were regarded as the benchmark for entering the study. Samples were cultured on the Mannitol salt agar medium (Merck, Germany) and were incubated at 35°C for 24-48 hours. Yellow colonies (mannitol fermenting and suspected to contain S. aureus) were again cultured on the same medium for further tests. S. aureus was identified through colony morphology, Gram staining, hemolysis, catalase, coagulase slide (clumping) and tube and DNase tests.
Minimum Inhibitory Concentration Determination
For this purpose, we used broth microdilution method. In this method, in the 96-well microplates containing 50 µL of Mueller-Hinton broth (Merck, Germany), 50 µL of the 1024 µg concentration was poured in the first well and dilution was performed in all wells. The stock solutions of mupirocin were diluted in sterilized distilled water to achieve drug concentrations of 0.016 to 1024 µg/ mL. Afterwards, 50 µL of the bacterial suspension with the final concentration of 1.5×10 8 CFU/mL were added to each well. At the end, microplates were incubated for 24 hours at 37°C. After incubation, the optical density (OD) of wells was read using Elisa Reader, and the first well without turbidity was regarded as minimum inhibitory concentration (MIC). Afterwards, the results of susceptibility and resistance of the strains to mupirocin were reported according to CLSI documents. 14 According to the instructions of this committee and other documents, 15 strains with MIC ≤4 µg/mL are sensitive, the ones with MIC = 8-256 µg/mL have low resistance and the ones with MIC ≥512 µg/mL are very resistant to mupirocin. In this method, S. aureus ATCC 25923 strain was used as the standard strain.
Antibacterial Properties of ZnONPs
In order to prepare various concentrations of ZnONPs, 0.8 g of ZnONPs powder with the size of 20 nm (Nanopishgaman, Iran) was added to a sterile tube containing 2 mL of sterile distilled water and dimethyl sulfoxide (DMSO) to reach the final concentration of 400 mg/mL (Figure 1 ). The tubes were shaken for 30 minutes, and sequential concentrations of 200, 100, 50, 25 and 12.5 mg/mL were prepared in distilled water. Afterwards, microbial suspension was prepared from all mupirocinresistant strains and cultured in the form of spreadsheet on the Mueller-Hinton agar medium which contained 2% salt. Then, wells with the diameter of 7 mm were drilled in the medium using sterile pipette Pasteur, and 100 uL of ZnO dilutions were inoculated into the wells. One well containing distilled water was considered as the negative control. Plates were incubated at 37°C. After 24 hours, the diameter of the inhibition zone created around each well was measured and recorded in millimeters. Zones with the diameter of over 12 mm were considered as susceptible to nanoparticles and the ones with the diameter of less than 10 mm were regarded as resistant to nanoparticles. Each stage of the test was repeated 3 times.
Statistical Analysis
To analyze the data, chi square and one-way analysis of variance (ANOVA) were performed using SPSS version 20.0. P < 0.001 was regarded as the significance level.
Results
Staphylococcus aureus isolates were obtained from various occupational groups including technicians, service staff (total number of each group = 37), nurses and physicians (total number of each group = 38) who were carriers of Staphylococcus (Table1). The strains were also studied in terms of susceptibility to mupirocin using broth microdilution method. The MIC range achieved for mupirocin in comparison with the MIC of the control strain was MIC<8 µg/mL, and 64.6% of S. aureus belonged to this range of MIC. Mupirocin with the MIC of 1024 µg/mL showed the best inhibitory effect. Three samples (6.2%) were in the range of MIC ≥512 µg/mL, and were regarded as high mupirocinresistant S. aureus, and 29.2% showed low resistance to this antibiotic. The results of antibacterial effects of ZnONPs showed that there was no significant difference between S. aureus strains with high and low resistance to mupirocin. In this study, the best and most effective inhibitory dose of nanoparticles was 400 mg/mL ( Table 2) .
Discussion
Today we face antibiotic resistance that has turned to a major challenge for medical community in treating infectious diseases. 3 Staphylococcus aureus is one of the most important causes of hospital infections. 4 Increasing antibiotic resistance may negate consumption of mupirocin and increase the costs and duration of the treatment. In this study, 32% of the hospital personnel carried S. aureus in their noses. In medical textbooks, the amount of S. aureus carriers among hospital staff is reported to be 70%-90% 16 which is considerably more than the amount reported in the present study. In a similar study carried out in Iran by Zeinalinia et al, 17 the amount of carriers was 26.8%, which was less than the amount reported in the present study. Nagant et al isolated 1971 strains of S. aureus, out of which 3.6% were resistant to mupirocin. 18 In the present study, 6.2% showed high resistance to mupirocin, which almost matches the results of the recent study. In the present study and in that of Lim's which was conducted in Kualalampour, the percentage of strains with lower resistance was more than those with higher resistance. 19 However, according to the study carried out by Joshi et al and the one by Chaturvedi et al in India and that of Babu et al during [2007] [2008] in the United States, the strains with higher resistance were more frequent. [20] [21] [22] The reason for such high resistance to mupirocin in these studies might be the indiscriminate consumption of the antibiotic or non-selection of proper anibiotic for treatment in those hospitals. In the study carried out by Saderi on 94 S. aureus isolates from 4 hospitals affiliated to the University of Tehran using PCR, 6 isolates were found to be resistant to mupirocin. Five isolates had low resistance and 1 showed high resistance. 23 In a study carried out on S. aureus nasal carriers in the staff of a hospital in Sweden, the highest amount of this bacterium was reported to be in male staff (33.3%). 24 This is in contrary to the present study, where the highest frequency was seen in female staff (52%). In another study conducted by Karamstaji et al, the highest frequency of S. aureus was found in the radiology and laboratory sections (26.66%) and the lowest frequency was found in the neonatal ward. 25 In the present study, the most and the least frequent carriers of S. aureus were the groups of nurses and technicians with 31.3% and 20.8%, respectively. Various studies have revealed that making use of mupirocin antibiotic can considerably reduce infections caused by staphylococci. However, increasing resistance may negate consumption of this antibiotic and increase the costs and duration of the treatment. One of the promising strategies for confronting bacterial resistance is to use metal nanoparticles. In this study, the antimicrobial activity of various concentrations of ZnONPs was studied on S. aureus resistant to mupirocin. In the present study, the antibacterial properties of zinc oxide nanoparticles were shown. Seil et al in the United States synthesized ZnONPs and studied their antibacterial properties on S. aureus, and showed that zinc oxide owns antibacterial effects. 26 Zhang et al studied the antimicrobial effects of variable concentrations of ZnONPs with different sizes on Escherichia coli. They found that the antimicrobial effect increased as the concentration of the nanoparticle was raised independent of their sizes. 27 Likewise, in the present study, the best inhibitory effect was seen when the concentration of the nanoparticle was increased to 400 mg/mL. Li et al studied the antimicrobial effects of ZnONPs on the coat of polyvinyl chloride film on S. aureus and E. coli. 28 They reported that ZnONPs better affected Gram-positive bacteria than Gram-negative ones, and the reason for this was the difference between the membrane structure of gram-positive and gram-negative bacteria as well as the difference in the thickness of their peptidoglycan. Grampositive bacteria such as S. aureus have multilayer and thick peptidoglycan, while the peptidoglycan is thiner in Gram-negative bacteria. However, their exterior membrane has lipopolysaccharide which is less permeable to certain antibiotics and antimicrobial agents.
Conclusion
The results revealed that S. aureus exists in the nose of hospital staff and therefore can possibly be transferred to others especially the hospitalized patients. Thus, in order to prevent outbreaks of infections, it is important that hospital staff consider washing hands as well as applying specific methods for isolating and making use of topical antimicrobial agents in order to reduce colonization in the nose and prevent further infections in clinical settings. Our results showed that ZnONPs have antibacterial effects, and their antimicrobial effect increases upon increasing the concentration of the nanoparticles.
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